StockGlow

Calidi Biotherapeutics, Inc. (CLDI)

Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease.

$1.64+0.10%Healthcare
Compare CLDI with
StockGlow Score
3
Bearish
BearishBullish
1 year ago-98.6%

The outlook

Calidi Biotherapeutics, Inc. currently reads as bearish based on below its 50- & 200-day averages, 0% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$2.0M
52-wk high
$117.12
52-wk low
$1.48
50-day avg
$2.39
200-day avg
$10.77
Trailing P/E
—

Similar stocks

AZTRAzitra, Inc.$0.13+0.46%VTAKCatheter Precision, Inc.$0.26-4.90%LRHCLa Rosa Holdings Corp.$1.02-2.75%BIVIBioVie Inc.$1.52+6.29%BDRXBiodexa Pharmaceuticals Plc$1.48+1.11%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy